LABD
Direxion Daily S&P Biotech Bear 3X ETF
LABD
Closed
$7.57
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
LABD was created on 2015-05-28 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.
Company
Direxion
Asset class
Equity
Inception date
2015
Investment segment
Health Care
ISIN
US25461H8530
Website
Key stats
Open
$7.51
Volume
35.10M
AUM
$126.55M
Prev. close
$7.52
Expense ratio
1.07%
P/E
0.00
$7.45
Day’s Range
$7.58
$5.81
52W Range
$23.02
What’s in the fund
10
Total holdings
GOLDMAN FINL SQ TRSRY INST 506
49.93%
DREYFUS GOVT CASH MAN INS
38.20%
GOLDMAN SACHS FIN GOV 465 INSTITUT
18.67%
DREYFUS TRSRY SECURITIES CASH MGMT
2.70%
SPSIBI SWAP ASSET LEG
-3.41%
SPSIBI SWAP ASSET LEG
-4.62%
SPSIBI SWAP ASSET LEG
-12.82%
SPSIBI SWAP ASSET LEG
-68.38%
SPSIBI SWAP ASSET LEG
-92.36%
Others
172.09%
Returns
Performance
_
Difference
_
Direxion Daily S&P Biotech Bear 3X ETF
Sep
29
Dividends
The last payment date was Sep 29, 2026
Div. per Share
$0.07
Div. Yield
0.94%
Div. Growth YoY
-6.06%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply